A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
Clinical trial NCT05912244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05912244
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-09
- Primary completion
- 2027-06-09
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.